全身性エリテマトーデス患者におけるセネリモドの有効性と安全性を評価する研究

基本情報

NCT ID

NCT05672576

ステータス

募集中

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

420

治験依頼者名

Viatris Inc.

概要

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to severe symptoms. The main questions it aims to answer are: * How well cenerimod works on top of the treatment already being administered. * How safe cenerimod is for adult patients with Systemic Lupus Erythematosus. Researchers will compare one dose of cenerimod and a placebo to see how well cenerimod works when it is added to the treatment already being administered. In this research study approximately 210 participants will receive cenerimod and approximately 210 participants will receive placebo for 12 months.

対象疾患

介入

依頼者（Sponsor）

実施施設 (7)